Release of complement regulatory proteins from ocular surface cells in infections
- 1 January 2000
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 21 (5) , 856-866
- https://doi.org/10.1076/ceyr.21.5.856.5539
Abstract
The decay accelerating factor (DAF or CD55) and the membrane inhibitor of reactive lysis (MIRL or CD59), two complement regulatory proteins that protect self cells from autologous complement-mediated injury, are attached to corneal and cqonjunctival epithelial cells by glycosylphos-phatidylinositol (GPI) anchors. We sought to 1) determine the frequency with which bacteria recovered from patients with infections of the eye elaborate factors that can remove these surface proteins from ocular cells, 2) determine the spectrum of bacteria from other sites that have similar effects, and 3) establish the time interval required for reconstitution of the two regulators. Culture supernatants of 18 ocular isolates [P. aeruginosa (n = 3), S. marcescens (n = 1), S. epidermidis (n = 9), and S. aureus (n = 5)], and > 100 other clinical specimens isolated in the hospital's microbiology laboratory [P. mirabilis (n = 1), S. aureus (n = 65), S. epidermidis (n = 24), B. cereus (n = 12), H. influenzae (n = 15), and Enterobacter sp. (n = 21)] were incubated at 37 degrees C for various times with conjunctival epithelial cells, conjunctival fibroblasts or HeLa cells and the release of DAF and CD59 proteins from the surfaces of the cells analyzed by 2-site immunoradiometric assays and by Western blotting. The kinetics of recovery of DAF and CD59 expression on the cells was measured by flow cytometry. DAF and/or CD59 release from the cell monolayers varied from < 5% to > 99% at as much as a 1:81 dilution of the supernatant from some bacteria. On conjunctival epithelial cells, more than 8 hr was required for 44% recovery of DAF expression and for 50% recovery of CD59 expression. Bacteria produce phospholipases and/or other enzymes which can efficiently remove DAF and CD59 from ocular cell surfaces. This phenomenon may correlate with their in vivo pathogenicity.Keywords
This publication has 22 references indexed in Scilit:
- SHORT COMMUNICATION: Detection of complement regulatory proteins on soft contact lensesCurrent Eye Research, 1997
- Modulation of the cleavage of glycosylphosphatidylinositol-anchored proteins by specific bacterial phospholipasesBiochemistry and Cell Biology, 1996
- Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal glandCurrent Eye Research, 1994
- Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59Clinical and Experimental Immunology, 1992
- Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositolMolecular Immunology, 1989
- Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1985
- Distribution of Hemolytic Complement in the Normal CorneaArchives of Ophthalmology (1950), 1981
- Hemolytic Complement Activity in Normal Human Donor CorneasArchives of Ophthalmology (1950), 1980
- Aeromonas hydrophila infection of a puncture woundAnnals of Emergency Medicine, 1980
- CHANGING VIRAL SUSCEPTIBILITY OF A HUMAN CELL LINE IN CONTINUOUS CULTIVATIONThe Journal of Experimental Medicine, 1961